Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)

Clinical trial NCT04670120 · UNKNOWN

Trial details

NCT number: NCT04670120
Sponsor: Beijing Chest Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sensitive Pulmonary Tuberculosis

Start date: 2021-03-01
Primary completion: 2021-06-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.